Skip to main content
Publish date:

ALERT: Halper Sadeh LLP Investigates ALXN, SPWH, CBMG, STND, EIDX; Shareholders Are Encouraged To Contact The Firm

NEW YORK, Jan. 5, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc.

NEW YORK, Jan. 5, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Alexion Pharmaceuticals, Inc. (ALXN) - Get Alexion Pharmaceuticals, Inc. Report  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share.  If you are an Alexion shareholder, click here to learn more about your rights and options .  

Sportsman's Warehouse Holdings, Inc. (SPWH) - Get Sportsman's Warehouse Holdings, Inc. Report  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Great American Outdoors Group for $18.00 per share in cash.  If you are a Sportsman's shareholder, click here to learn more about your rights and options .  

Cellular Biomedicine Group, Inc. (CBMG) - Get Cellular Biomedicine Group, Inc. Report  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. If you are a Cellular Biomedicine shareholder, click here to learn more about your rights and options .

Standard AVB Financial Corp. (STND) - Get Standard AVB Financial Corp Report concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Dollar Mutual Bancorp for $33.00 per share.  If you are a Standard AVB shareholder, click here to learn more about your rights and options .

Eidos Therapeutics, Inc. (EIDX) - Get Eidos Therapeutics Inc Report concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to BridgeBio Pharma, Inc.  Under the merger agreement, Eidos stockholders will receive either 1.85 shares of BridgeBio common stock or $73.26 in cash for each share of Eidos common stock owned.  If you are an Eidos shareholder, click here to learn more about your rights and options . 

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:Halper Sadeh LLP Daniel Sadeh, Esq. Zachary Halper, Esq.(212) 763-0060 sadeh@halpersadeh.com zhalper@halpersadeh.com  https://www.halpersadeh.com

View original content to download multimedia: http://www.prnewswire.com/news-releases/alert-halper-sadeh-llp-investigates-alxn-spwh-cbmg-stnd-eidx-shareholders-are-encouraged-to-contact-the-firm-301201109.html

SOURCE Halper Sadeh LLP